Apr 05, 2024
1:30
For every 30 shares held, investors received 1. The price per share adjusted from $0.44 to $0.01.
The split itself did not change the total investment value.
Cartesian Therapeutics, Inc. (RNAC) trades on the NASDAQ in the Biotechnology industry.
Cartesian Therapeutics, Inc. company overviewThe latest split shown was on April 5, 2024. It was a 1-for-30 reverse split, so shareholders received 1 share for every 30 they held.
This history records one reverse split, on April 5, 2024.